Bioarray Therapeutics
Latest round
- Series B
Last raised
- Oct 2017
Total raised
- $5.3M
Investors
- 3
About Bioarray Therapeutics
Bioarray Therapeutics Inc.Founded in 2009 in Farmington, US, Bioarray Therapeutics Inc. specializes in biotechnological solutions for diagnostic applications.Bioarray Therapeutics Inc. specializes in advanced biotechnological solutions, primarily focusing on the development and provision of innovative array-based diagnostics tools. Their core product offerings include high-throughput bioassay platforms that enable the detection and analysis of biological samples for various applications in research, clinical diagnostics, and agricultural biotechnology. These products address critical challenges in health and environmental monitoring, such as early disease detection and pathogen identification, which are vital in both clinical settings and agricultural practices. The end users of these products range from clinical laboratories, research institutions, and healthcare providers to agricultural enterprises looking to enhance crop disease management. Bioarray Therapeutics Inc.The revenue model of Bioarray Therapeutics Inc. is primarily structured around direct sales of their diagnostic products and services to both businesses and end consumers. Transactions typically occur through B2B partnerships with healthcare institutions, research organizations, and agricultural firms, allowing for tailored solutions that meet specific client needs. Pricing plans may include one-time purchases for individual products or tiered pricing for bulk orders, catering to the scale of the client’s requirements. Additionally, the company may offer service packages that include ongoing support and maintenance for their diagnostic platforms, which further enhances client retention and satisfaction. Overall, Bioarray Therapeutics Inc.In October 2017, Bioarray Therapeutics Inc. The company plans to expand its market reach, targeting specific regions in Asia and Europe for new partnerships and sales channels by the end of 2023.
Who invested in Bioarray Therapeutics
3 investors across 2 rounds
See all investors in Bioarray Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bioarray Therapeutics
Who invested in Bioarray Therapeutics?
Bioarray Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bioarray Therapeutics raised?
Bioarray Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bioarray Therapeutics last raise money?
Bioarray Therapeutics's most recent round on record is a Series B, in Oct 2017.
What does Bioarray Therapeutics do?
Bioarray Therapeutics is a biotechnology company.
Where is Bioarray Therapeutics headquartered?
Bioarray Therapeutics is headquartered in Farmington, US.
Which VCs invest in companies like Bioarray Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bioarray Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Bioarray Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.